Across TCGA pan-cancer cohorts, SNORD116-29 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SNORD116-29 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SNORD116-29 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD116-29 expression acts as an unfavorable survival marker.

STAD are the cancer types where SNORD116-29 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	II,III,IV	0.537	0.677	.009	17	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SNORD116-29 tumor-vs-normal RNA expression · all SNORD116-29 data types